Search research articles
Contact Us
Filters
Showing results (31-40 of 82) with videos related to
Page
of 9
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation
|
October 14, 2016
Amphiphysin-positive paraneoplastic myelitis and stiff-person syndrome
Simon Faissner, Carsten Lukas, Anke Reinacher-Schick, et al.
Frontiers in Immunology
|
May 20, 2021
Clozapine Regulates Microglia and Is Effective in Chronic Experimental Autoimmune Encephalomyelitis
Ulaş Ceylan, Steffen Haupeltshofer, Laura Kämper, et al.
Therapeutic Advances in Neurological Disorders
|
February 19, 2024
Eomesodermin-expressing CD4+ Th cells and association with pregnancy in multiple sclerosis
Simon Faissner, Marielena Bongert, Paulina Trendelenburg, et al.
Journal of the American Geriatrics Society
|
October 22, 2014
Atypical occipital calcinosis in a Caucasian individual with probable diffuse neurofibrillary tangles with calcification
Simon Faissner, Robert Hoepner, Gisa Ellrichmann, et al.
Therapeutic Advances in Neurological Disorders
|
November 13, 2025
Chimeric antigen receptor T-cell therapy for stiff-person syndrome: bridging innovation and clinical challenges in neuroimmunology
Jonathan Wickel, Jeremias Motte, Ilya Ayzenberg, et al.
Leukemia Research Reports
|
June 13, 2018
1,25-OH<sub>2</sub> vitamin D<sub>3</sub> and AKT-inhibition increase glucocorticoid induced apoptosis in a model of T-cell acute lymphoblastic leukemia (ALL)
Maximilian Pistor, Lisa Schrewe, Steffen Haupeltshofer, et al.
Journal of Neurology
|
April 4, 2016
Plasmapheresis and immunoadsorption in patients with steroid refractory multiple sclerosis relapses
Simon Faissner, Johanna Nikolayczik, Andrew Chan, et al.
Therapeutic Advances in Neurological Disorders
|
January 30, 2023
Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis - a review of population-specific evidence from randomized clinical trials
Antonios Bayas, Monika Christ, Simon Faissner, et al.
Frontiers in Immunology
|
June 30, 2025
Corrigendum: Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series
Regina Berkovich, Jonathan Calkwood, Heidi Crayton, et al.
Neurological Research and Practice
|
August 17, 2021
Multiple sclerosis is not associated with an increased risk for severe COVID-19: a nationwide retrospective cross-sectional study from Germany
Daniel Richter, Simon Faissner, Dirk Bartig, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 82) with videos related to
Sort By:
Page
of 9
Neurology(R) Neuroimmunology & Neuroinflammation
|
October 14, 2016
Amphiphysin-positive paraneoplastic myelitis and stiff-person syndrome
Simon Faissner, Carsten Lukas, Anke Reinacher-Schick, et al.
Frontiers in Immunology
|
May 20, 2021
Clozapine Regulates Microglia and Is Effective in Chronic Experimental Autoimmune Encephalomyelitis
Ulaş Ceylan, Steffen Haupeltshofer, Laura Kämper, et al.
Therapeutic Advances in Neurological Disorders
|
February 19, 2024
Eomesodermin-expressing CD4+ Th cells and association with pregnancy in multiple sclerosis
Simon Faissner, Marielena Bongert, Paulina Trendelenburg, et al.
Journal of the American Geriatrics Society
|
October 22, 2014
Atypical occipital calcinosis in a Caucasian individual with probable diffuse neurofibrillary tangles with calcification
Simon Faissner, Robert Hoepner, Gisa Ellrichmann, et al.
Therapeutic Advances in Neurological Disorders
|
November 13, 2025
Chimeric antigen receptor T-cell therapy for stiff-person syndrome: bridging innovation and clinical challenges in neuroimmunology
Jonathan Wickel, Jeremias Motte, Ilya Ayzenberg, et al.
Leukemia Research Reports
|
June 13, 2018
1,25-OH<sub>2</sub> vitamin D<sub>3</sub> and AKT-inhibition increase glucocorticoid induced apoptosis in a model of T-cell acute lymphoblastic leukemia (ALL)
Maximilian Pistor, Lisa Schrewe, Steffen Haupeltshofer, et al.
Journal of Neurology
|
April 4, 2016
Plasmapheresis and immunoadsorption in patients with steroid refractory multiple sclerosis relapses
Simon Faissner, Johanna Nikolayczik, Andrew Chan, et al.
Therapeutic Advances in Neurological Disorders
|
January 30, 2023
Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis - a review of population-specific evidence from randomized clinical trials
Antonios Bayas, Monika Christ, Simon Faissner, et al.
Frontiers in Immunology
|
June 30, 2025
Corrigendum: Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series
Regina Berkovich, Jonathan Calkwood, Heidi Crayton, et al.
Neurological Research and Practice
|
August 17, 2021
Multiple sclerosis is not associated with an increased risk for severe COVID-19: a nationwide retrospective cross-sectional study from Germany
Daniel Richter, Simon Faissner, Dirk Bartig, et al.
Page
of 9